Education
About Us
Working with TipRanks
Follow Us
Affimed (AFMDQ)
OTHER OTC:AFMDQ
Afm13, Cyclophosphamide, Fludarabine, Interleukin-2, Ab-101
Peripheral T Cell Lymphoma, Relapsed Or Refractory Hodgkin Lymphoma
Phase II
Terminated
Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCL
May 19, 2023
―
Afm28
Acute Myeloid Leukemia
Phase I
Terminated
First-in-Human Dose Escalation Study of AFM28 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Mar 22, 2023
―
Afm24, Atezolizumab 840 Mg In 14 Ml Injection
Advanced Solid Tumor
Phase I/II
Terminated
Study to Assess AFM24 in Combination With Atezolizumab in Selected Advanced/Metastatic EGFR-expressing Cancers
Oct 01, 2021
―
14 Mg Afm24, 40 Mg Afm24, 80 Mg Afm24, 160 Mg Afm24, 320 Mg Afm24, 480 Mg Afm24, 720 Mg Afm24
Advanced Solid Tumor
Phase I/II
Terminated
Study to Assess AFM24 in Advanced Solid Cancers
Feb 03, 2020
―
Afm13
Peripheral T Cell Lymphoma, Transformed Mycosis Fungoides
Phase II
Completed
Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides
Sep 20, 2019
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Affimed (AFMDQ) have in its pipeline
AFMDQ is currently developing the following drugs: Afm13, Cyclophosphamide, Fludarabine, Interleukin-2, Ab-101, Afm28, Afm24, Atezolizumab 840 Mg In 14 Ml Injection. These drug candidates are in various stages of clinical development as the company works toward FDA approval.